AFG
VRTX icon

Albion Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Albion Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,077
Closed -$488K – 778
2025
Q4 		$488K Sell
1,077
-32
-3% -$13.8K 0.03% 130
2025
Q3 		$434K Sell
1,109
-4
-0.4% -$1.67K 0.03% 134
2025
Q2 		$496K Hold
1,113
– – 0.03% 134
2025
Q1 		$540K Sell
1,113
-227
-17% -$106K 0.04% 142
2024
Q4 		$540K Buy
1,340
+42
+3% +$19.5K 0.04% 141
2024
Q3 		$604K Sell
1,298
-22
-2% -$10.6K 0.04% 134
2024
Q2 		$619K Sell
1,320
-75
-5% -$32.6K 0.05% 129
2024
Q1 		$583K Buy
1,395
+57
+4% +$24.1K 0.05% 131
2023
Q4 		$544K Buy
1,338
+200
+18% +$73.9K 0.04% 137
2023
Q3 		$396K Sell
1,138
-2
-0.2% -$699 0.04% 140
2023
Q2 		$401K Sell
1,140
-223
-16% -$75.1K 0.04% 143
2023
Q1 		$429K Buy
1,363
+25
+2% +$7.5K 0.04% 134
2022
Q4 		$386K Sell
1,338
-49
-4% -$14.9K 0.04% 140
2022
Q3 		$402K Buy
1,387
+40
+3% +$11.5K 0.04% 135
2022
Q2 		$380K Sell
1,347
-524
-28% -$140K 0.04% 143
2022
Q1 		$488K Buy
1,871
+302
+19% +$71.7K 0.04% 148
2021
Q4 		$345K Sell
1,569
-403
-20% -$78.4K 0.03% 181
2021
Q3 		$358K Hold
1,972
– – 0.03% 158
2021
Q2 		$398K Buy
+1,972
New +$412K 0.03% 155
2020
Q4 		$467K Sell
1,977
-11
-0.6% -$2.52K 0.05% 144
2020
Q3 		$541K Buy
+1,988
New +$548K 0.06% 147

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Albion Financial Group's VRTX Position: Q1 2026 in Review

Albion Financial Group sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 1,077 shares — an estimated $488K sold.

Albion Financial Group first reported a position in VRTX in Q3 2020 and held it in 21 quarters. The position peaked at $619K in Q2 2024. 1,695 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Albion Financial Group reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Albion Financial Group sold 1,077 Vertex Pharmaceuticals shares in Q1 2026, an estimated $488K.
  • Albion Financial Group first reported a position in Vertex Pharmaceuticals in Q3 2020 and held it in 21 quarters.
  • Albion Financial Group's Vertex Pharmaceuticals position peaked at $619K in Q2 2024.
  • 1,695 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.